Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGX-4010 for neuropathic pain (C114 extension)
NCT00089557Phase 2Terminated
- Sponsor
- NeurogesX
- Modality
- Transdermal Patches, Small Molecules
01
Overview
A Phase 2 trial of capsaicin 8% patch in neuropathic pain, sponsored by NeurogesX. Status: terminated.
02
Drugs
capsaicin 8% patch
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT00089557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089557.